Company / R&D Expense
Teladoc Health, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$277.9M
FY2025
5-year range
$277.9M / $348.5M
FY2021-FY2025
Trend
-9.6%
vs FY2024
Sector context
#25 of 105
Health Care
What the data says
Teladoc Health, Inc.'s r&d expense of $278M is higher than 76% of companies in the Health Care sector (FY2025). Declined from $349M to $278M over the past 2 years.
Based on SEC 10-K filings.
$278M in FY2025 with a 5-year CAGR of +11.0%. Top quartile in the Health Care sector.
Declined from $349M to $278M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -5.9%
- 5-Year CAGR
- +11.0%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 105This company $277.9M Sector average $284.2M
▼
-2.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.0%, indicating consistent growth.
- In FY2025, r&d expense decreased 9.6% year-over-year.
- Ranks #25 out of 105 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $277.9M | -9.6% |
| FY2024 | $307.3M | -11.8% |
| FY2023 | $348.5M | +4.5% |
| FY2022 | $333.6M | +7.0% |
| FY2021 | $311.9M | +89.1% |
| FY2020 | $164.9M | +155.2% |
| FY2019 | $64.6M | +18.9% |
| FY2018 | $54.4M | +57.8% |
| FY2017 | $34.5M | +58.0% |
| FY2016 | $21.8M | +53.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026